Chong Kun Dang Enters the Hypertension Treatment Market: Should Investors Pay Attention to Telminuvo’s Approval? Chong Kun Dang’s newly developed hypertension treatment, Telminuvo, has received approval from the Ministry of Food and Drug Safety (MFDS). How will this news impact Chong Kun Dang Holdings’ stock price? This article delves into the significance of Telminuvo’s approval, … Read more
A New Game Changer in the Hypertension Treatment Market? News of Chong Kun Dang’s application for approval of its new hypertension drug ‘Telminuvo’ has caught the attention of investors. Expected to launch in the second half of 2025, what impact will this new drug have on the growth of Chong Kun Dang Holdings? This article … Read more
Chong Kun Dang Holdings CEO Increases Stake: What Does it Mean for Investors? CEO Lee Jang-han’s recent stake purchase in Chong Kun Dang Holdings has sparked investor curiosity. Is this a simple move or a significant signal for the stock’s future? This article analyzes the company’s Q1 2025 earnings, the rationale behind the stake purchase, … Read more